InvestorsHub Logo
Followers 2
Posts 79
Boards Moderated 0
Alias Born 06/23/2014

Re: None

Friday, 03/06/2015 3:32:20 PM

Friday, March 06, 2015 3:32:20 PM

Post# of 80490
On 15 January 2015, orphan designation (EU/3/14/1421) was granted by the European Commission to ARIAD Pharma Ltd, United Kingdom, for ponatinib hydrochloride for the treatment of gastrointestinal stromal tumours.
European Medicines Agency
pdf published 06/03/2015

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.